Lay of the land: Understanding lay summary requirements and the challenges they bring
Pharmaceutical Technology
OCTOBER 28, 2022
Designed to explain either the risk management plan (RMP) or clinical trial results (CTR) in a way that a child can understand, lay summaries are now a required document for all clinical trials in the European Union (EU) following changes to EU Clinical Trials Regulations (EU-CTR) regulations earlier this year.
Let's personalize your content